≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Congenital ptosis

Endpoint Browser PheWeb

Q17_CONGENITAL_PTOSIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q10.0
  • Cause of death: ICD-10 — Q10.0

2 out of 7 registries used, show all original rules.

129

4. Check minimum number of events

None

129

5. Include endpoints

None

129

6. Filter based on genotype QC (FinnGen only)

125

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 125 66 59
Unadjusted period prevalence (%) 0.03 0.02 0.03
Median age at first event (years) 25.06 23.94 26.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
129
Matched controls
1290
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q10.0
ICD-10 Finland
Congenital ptosis
+∞
186.3
129
*
H02.4
ICD-10 Finland
Ptosis of eyelid
121.7
54.5
56
8
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
500.3
38.1
36
*
CBJ10
NOMESCO Finland
Fascia plate sling or synthetic material for ptosis correction
+∞
25.9
24
*
74482
ICD-8 Finland
Congenital anomalies of eye, Ptosis
+∞
17.0
16
*
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
+∞
13.8
13
*
XCK10
NOMESCO Finland
Photography of fundus of eye
5.7
11.2
23
47
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
3.3
9.9
60
270
3242
FHL
Levator resection
+∞
9.5
9
*
CBJ99
NOMESCO Finland
Other operation for ptosis
+∞
8.4
8
*
7436B
ICD-9 Finland
Congenital anomalies of eyelids, lachrymal system and orbit[PTOSIS CONGENITA]
+∞
8.4
8
*
3743A
ICD-9 Finland
Other disorders of eyelids, Ptosis of eyelid[PTOSIS]
+∞
7.4
7
*
ZXD20
NOMESCO Finland
Day surgery
3.8
7.0
24
74
ZXA10
NOMESCO Finland
Bilateral
3.2
6.8
32
121
ZXD10
NOMESCO Finland
Scheduled procedure
2.6
6.1
55
291
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
6.0
50
255

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Ophthalmology
18 [38004463]
8.2e-01
1.4e+00
1.4e+00
1.0e+50
2.7e+00
3.1e+00
1.4e+00
cases:22.86%
controls:11.58%
cases:22.52%
controls:6.85%
cases:4.50%
controls:1.20%
cases:82.88%
controls:0.00%
cases:17.12%
controls:1.40%
cases:63.89%
controls:7.23%
cases:47.12%
controls:17.55%
24
119
81
909
25
74
86
1006
5
13
106
1067
92
0
19
1080
19
15
92
1059
69
75
39
963
49
176
55
827
Nonallergic asthma
J45.1 [45557625]
1.9e+00
2.5e+00
—
—
—
1.8e+00
1.2e+00
cases:7.62%
controls:1.26%
cases:6.31%
controls:0.56%
—
—
—
—
—
—
cases:4.63%
controls:0.77%
cases:5.77%
controls:1.89%
8
13
97
1015
7
6
104
1074
—
—
—
5
8
103
1030
6
19
98
984
Scheduled procedure
ZXD10 [2001311387]
6.0e-01
2.8e-01
—
—
—
2.4e+00
1.5e+00
cases:10.48%
controls:6.03%
cases:4.50%
controls:3.43%
—
—
—
—
—
—
cases:15.74%
controls:1.64%
cases:14.42%
controls:3.79%
11
62
94
966
5
37
106
1043
—
—
—
17
17
91
1021
15
38
89
965
Case Management Agency
251B00000X [38004193]
-1.8e-01
5.8e-02
7.9e-01
2.8e+00
4.4e-01
1.4e-01
3.0e-02
cases:36.19%
controls:40.47%
cases:37.84%
controls:36.48%
cases:27.03%
controls:14.44%
cases:15.32%
controls:1.11%
cases:20.72%
controls:14.43%
cases:41.67%
controls:38.25%
cases:52.88%
controls:52.14%
38
416
67
612
42
394
69
686
30
156
81
924
17
12
94
1068
23
155
88
919
45
397
63
641
55
523
49
480
Bilateral
ZXA10 [2001311348]
—
-1.0e+50
—
—
—
2.8e+00
—
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
cases:10.19%
controls:0.67%
—
—
—
0
10
111
1070
—
—
—
11
7
97
1031
—
Acute conjunctivitis, unspecified
H10.3 [45566958]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.73%
controls:0.60%
—
—
—
—
—
—
7
6
97
997
Supplier / Service Provider
OMOP5117446 [33004]
-7.6e-01
—
-1.0e+50
—
—
—
2.4e+00
cases:11.43%
controls:21.69%
—
—
cases:0.00%
controls:1.76%
—
—
—
—
—
—
cases:15.38%
controls:1.60%
12
223
93
805
—
0
19
111
1061
—
—
—
16
16
88
987
Photography of fundus of eye
XCK10 [2001301381]
—
—
—
1.0e+50
—
2.0e+00
8.7e-01
—
—
—
—
—
—
cases:7.21%
controls:0.00%
—
—
cases:6.48%
controls:0.96%
cases:5.77%
controls:2.49%
—
—
—
8
0
103
1080
—
7
10
101
1028
6
25
98
978
One hour or less
ZXE00 [2001311394]
6.3e-01
—
—
—
—
1.6e+00
9.1e-01
cases:12.38%
controls:7.00%
—
—
—
—
—
—
—
—
cases:12.96%
controls:2.79%
cases:9.62%
controls:4.09%
13
72
92
956
—
—
—
—
14
29
94
1009
10
41
94
962
chloramphenicol
S01AA01 [21603554]
3.3e-01
8.7e-01
—
—
—
1.5e+00
6.5e-01
cases:6.67%
controls:4.86%
cases:4.50%
controls:1.94%
—
—
—
—
—
—
cases:8.33%
controls:1.93%
cases:15.38%
controls:8.67%
7
50
98
978
5
21
106
1059
—
—
—
9
20
99
1018
16
87
88
916
chloramphenicol
S03AA08 [21605197]
3.3e-01
8.7e-01
—
—
—
1.5e+00
6.5e-01
cases:6.67%
controls:4.86%
cases:4.50%
controls:1.94%
—
—
—
—
—
—
cases:8.33%
controls:1.93%
cases:15.38%
controls:8.67%
7
50
98
978
5
21
106
1059
—
—
—
9
20
99
1018
16
87
88
916
Outpatient Visit
OP [9202]
2.3e-01
1.3e-01
5.3e-01
—
7.8e-01
1.4e+00
5.6e-01
cases:65.71%
controls:60.41%
cases:50.45%
controls:47.13%
cases:18.02%
controls:11.48%
—
—
cases:22.52%
controls:11.73%
cases:77.78%
controls:47.50%
cases:81.73%
controls:71.78%
69
621
36
407
56
509
55
571
20
124
91
956
—
25
126
86
948
84
493
24
545
85
720
19
283
Infiltration anesthesia
WX110 [2001310767]
6.2e-01
4.4e-01
-1.0e+50
—
—
1.2e+00
2.4e-03
cases:16.19%
controls:9.44%
cases:9.01%
controls:6.02%
cases:0.00%
controls:1.02%
—
—
—
—
cases:14.81%
controls:5.01%
cases:15.38%
controls:15.35%
17
97
88
931
10
65
101
1015
0
11
111
1069
—
—
16
52
92
986
16
154
88
849
Outpatient Hospital
22 [8756]
3.0e-01
-2.7e-01
-1.0e+50
—
—
1.1e+00
2.7e-01
cases:29.52%
controls:23.74%
cases:7.21%
controls:9.26%
cases:0.00%
controls:0.93%
—
—
—
—
cases:17.59%
controls:6.45%
cases:20.19%
controls:16.15%
31
244
74
784
8
100
103
980
0
10
111
1070
—
—
19
67
89
971
21
162
83
841
cefalexin; oral
J01DB01 [21602870]
5.2e-01
5.2e-01
—
—
—
1.0e+00
3.3e-01
cases:40.95%
controls:29.28%
cases:13.51%
controls:8.52%
—
—
—
—
—
—
cases:22.22%
controls:9.25%
cases:34.62%
controls:27.52%
43
301
62
727
15
92
96
988
—
—
—
24
96
84
942
36
276
68
727
salbutamol; inhalant
R03AC02 [21603256]
5.7e-01
6.2e-01
—
—
—
8.4e-01
9.9e-01
cases:15.24%
controls:9.24%
cases:10.81%
controls:6.11%
—
—
—
—
—
—
cases:12.04%
controls:5.59%
cases:27.88%
controls:12.56%
16
95
89
933
12
66
99
1014
—
—
—
13
58
95
980
29
126
75
877
Inpatient Hospital
21 [8717]
1.6e-01
-2.0e-01
-1.0e+50
—
—
9.3e-01
1.4e-01
cases:39.05%
controls:35.41%
cases:9.91%
controls:11.85%
cases:0.00%
controls:1.67%
—
—
—
—
cases:23.15%
controls:10.60%
cases:27.88%
controls:25.12%
41
364
64
664
11
128
100
952
0
18
111
1062
—
—
25
110
83
928
29
252
75
751
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.02%
—
—
—
—
—
—
—
—
—
—
—
0
11
111
1069
—
—
—
—
—
Sprain and strain involving (anterior)(posterior) cruciate ligament of knee
S83.5 [45608523]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
89640-7 [1175715]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.68%
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
0
5
111
1075
—
—
—
—
—
doxycycline; oral, parenteral
J01AA02 [21602800]
-1.4e-01
4.2e-01
—
—
—
—
4.3e-01
cases:11.43%
controls:12.94%
cases:5.41%
controls:3.61%
—
—
—
—
—
—
—
—
cases:16.35%
controls:11.27%
12
133
93
895
6
39
105
1041
—
—
—
—
17
113
87
890
Other and unspecified convulsions
R56.8 [45602033]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.97%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.10%
0
10
105
1018
—
—
—
—
—
0
11
104
992
Central perforation of tympanic membrane
H72.0 [45538342]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:1.10%
—
0
5
111
1075
—
—
—
0
6
108
1032
0
11
104
992
desonide
D07AB08 [21602112]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
—
—
—
—
—
—
0
12
104
991
Routine child health examination
Z00.1 [45561606]
—
7.7e-01
—
—
—
—
—
—
—
cases:4.50%
controls:2.13%
—
—
—
—
—
—
—
—
—
—
—
5
23
106
1057
—
—
—
—
—
Nausea and vomiting
R11 [45539317]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
0
6
108
1032
—
Supine thorax X-ray examination
GD1QA [2001303648]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Fungus identified in Specimen by Culture
580-1 [3000494]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
0
5
111
1075
—
—
—
0
8
108
1030
—
Conjunctivitis, unspecified
H10.9 [45591253]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.67%
—
—
—
—
—
—
—
0
7
108
1031
—
No disease
A97 [2002000230]
—
—
—
—
—
—
7.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.81%
controls:2.29%
—
—
—
—
—
—
5
23
99
980
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
—
0
6
111
1068
—
—
Other specified pulpit
K04.08 [2000502703]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.40%
—
—
—
—
—
—
0
14
104
989
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
8
104
995
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
MA2AE [2001306829]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.67%
—
—
—
—
—
—
—
0
7
108
1031
—
Type 2 diabetes mellitus
E11 [45571656]
—
—
—
—
—
2.0e+00
4.9e-01
—
—
—
—
—
—
—
—
—
—
cases:4.63%
controls:0.67%
cases:4.81%
controls:2.99%
—
—
—
—
—
5
7
103
1031
5
30
99
973
Blasts/Leukocytes in Blood
26446-5 [3025159]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.49%
cases:0.00%
controls:0.56%
—
—
—
—
—
—
cases:0.00%
controls:0.67%
cases:0.00%
controls:1.30%
0
5
105
1023
0
6
111
1074
—
—
—
0
7
108
1031
0
13
104
990
Rash localized
S06 [2002000971]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
cases:0.00%
controls:0.80%
—
—
—
—
—
0
5
108
1033
0
8
104
995
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
3193-0 [3005757]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.93%
—
—
—
—
—
—
cases:0.00%
controls:0.67%
cases:0.00%
controls:0.60%
—
0
10
111
1070
—
—
—
0
7
108
1031
0
6
104
997
Cystitis, unspecified
N30.9 [45606488]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.00%
—
—
—
—
—
—
0
10
104
993
Risk factor cardiovascular disease
K22 [2002000551]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
0
6
105
1022
—
—
—
—
—
0
7
104
996
diclofenac
D11AX18 [21602355]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.46%
—
—
—
—
—
—
—
—
—
—
—
—
0
15
105
1013
—
—
—
—
—
—
Treatment of a patient needing special arrangements
WYA30 [2001310874]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.10%
—
—
—
—
—
—
0
11
104
992
Respiratory symptom/complaint other
R29 [2002000898]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.68%
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
0
5
111
1075
—
—
—
—
—
dexamethasone and antiinfectives
S03CA01 [21605206]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.79%
—
—
—
—
—
—
0
18
104
985
Biopsy of prostate with ultrasoudnguidance
KE1AT [2001306172]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Operation for osteochondritis of knee, arthroscopic
NGF25 [2001308133]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Release of median nerve
ACC51 [2001300642]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2500B [2000402295]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.36%
—
—
—
—
—
—
—
—
—
—
—
—
0
14
105
1014
—
—
—
—
—
—
Tooth X-ray additional picture
EB1CA [2001301909]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.97%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
105
1018
—
—
—
—
—
—
High dependency care
WX882 [2001310847]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
—
0
13
111
1067
—
—
—
—
—
doxylamine; oral
R06AA09 [21603453]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11054-4 [3002109]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.97%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
105
1018
—
—
—
—
—
—
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-4.0e-02
-4.1e-01
—
—
8.6e-01
-1.9e-02
2.9e-01
cases:14.29%
controls:14.79%
cases:9.01%
controls:12.96%
—
—
—
—
cases:4.50%
controls:1.96%
cases:12.04%
controls:12.24%
cases:31.73%
controls:25.72%
15
152
90
876
10
140
101
940
—
—
5
21
106
1053
13
127
95
911
33
258
71
745
Insertion of (intrauterine) contraceptive device
Z30.1 [45537626]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.78%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
105
1020
—
—
—
—
—
—
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:2.22%
—
—
—
—
—
—
cases:0.00%
controls:1.73%
—
—
—
0
24
111
1056
—
—
—
0
18
108
1020
—
Exposure to other specified factors
X58 [45756411]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Generalized anxiety disorder
F41.1 [45571764]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.30%
—
0
5
111
1075
—
—
—
—
0
13
104
990
Hypertension uncomplicated
K86 [2002000613]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.67%
cases:0.00%
controls:1.20%
—
—
—
—
—
0
7
108
1031
0
12
104
991
terbinafine; oral
D01BA02 [21601967]
—
-1.0e+50
—
—
—
—
1.4e+00
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
—
—
cases:5.77%
controls:1.50%
—
0
8
111
1072
—
—
—
—
6
15
98
988
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.78%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
0
8
105
1020
—
—
—
—
0
6
108
1032
—
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.7e-01
—
—
—
-1.0e+50
—
3.1e-01
cases:4.76%
controls:3.02%
—
—
—
—
—
—
cases:0.00%
controls:1.12%
—
—
cases:10.58%
controls:7.98%
5
31
100
997
—
—
—
0
12
111
1062
—
11
80
93
923
losartan and diuretics
C09DA01 [21601834]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
0
6
111
1074
—
—
—
—
apixaban; oral
B01AF02 [43534762]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Spacing, abnormal of tooth or teeth
K07.30 [2000502776]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.50%
—
—
—
—
—
—
0
15
104
988
Eye discharge
F03 [2002000401]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
—
—
—
—
—
0
5
108
1033
—
Chronic arrhythmias
207 [2001600205]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.49%
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
0
5
111
1075
—
—
—
—
—
Thorax X-ray examination
GD1AA [2001303617]
—
—
—
—
—
—
4.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.69%
controls:5.08%
—
—
—
—
—
—
8
51
96
952
hydrocortisone
C05AA01 [21601608]
1.5e-01
1.5e-01
—
—
—
—
-4.5e-01
cases:8.57%
controls:7.49%
cases:4.50%
controls:3.89%
—
—
—
—
—
—
—
—
cases:5.77%
controls:8.77%
9
77
96
951
5
42
106
1038
—
—
—
—
6
88
98
915
Anomalies of dental arch relationship
K07.22 [2000502768]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Lumbar puncture
TAB00 [2001300538]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.74%
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
—
0
8
111
1072
—
—
—
0
5
108
1033
—
Foot/toe symptom/complaint
L17 [2002000641]
4.7e-01
—
—
—
—
—
—
cases:4.76%
controls:3.02%
—
—
—
—
—
—
—
—
—
—
—
—
5
31
100
997
—
—
—
—
—
—
Contusion of other parts of wrist and hand
S60.2 [45602941]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
—
—
-1.0e+50
—
-1.0e+50
-1.0e+50
7.9e-01
—
—
—
—
cases:0.00%
controls:0.56%
—
—
cases:0.00%
controls:0.47%
cases:0.00%
controls:1.54%
cases:5.77%
controls:2.69%
—
—
0
6
111
1074
—
0
5
111
1069
0
16
108
1022
6
27
98
976
Old myocardial infarction
I25.2 [45601025]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.78%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
105
1020
—
—
—
—
—
—
Pain in thoracic spine
M54.6 [45606247]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
8
104
995
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-9.1e-02
—
—
—
-1.0e+50
—
1.4e-01
cases:5.71%
controls:6.23%
—
—
—
—
—
—
cases:0.00%
controls:1.30%
—
—
cases:12.50%
controls:11.07%
6
64
99
964
—
—
—
0
14
111
1060
—
13
111
91
892
Acute suppurative otitis media
H66.0 [45572040]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.16%
—
—
—
—
—
—
—
0
12
108
1026
—
Retrognaty, mandibular
K07.13 [2000502762]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
cases:0.00%
controls:0.60%
—
—
—
—
—
0
5
108
1033
0
6
104
997
Dysuria/painful urination
U01 [2002001137]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
combinations of corticosteroids
D07XB30 [21602188]
3.1e-01
—
-1.0e+50
—
—
—
-2.4e-01
cases:11.43%
controls:8.66%
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
cases:8.65%
controls:10.77%
12
89
93
939
—
0
5
111
1075
—
—
—
9
108
95
895
hepatitis A, inactivated, whole virus
J07BC02 [21601339]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
105
1019
—
—
—
—
—
—
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Photocoagulation of retina
CKC12 [2001301394]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Emergency Medicine
93 [38004510]
-7.3e-03
7.3e-01
-1.0e+50
—
—
3.3e-01
3.3e-02
cases:6.67%
controls:6.71%
cases:7.21%
controls:3.61%
cases:0.00%
controls:0.93%
—
—
—
—
cases:5.56%
controls:4.05%
cases:15.38%
controls:14.96%
7
69
98
959
8
39
103
1041
0
10
111
1070
—
—
6
42
102
996
16
150
88
853
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
—
—
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
cases:0.00%
controls:1.93%
cases:0.00%
controls:3.49%
—
—
—
—
0
6
111
1068
0
20
108
1018
0
35
104
968
Insulin glargine 300 U / ml
177 [2001600176]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
cases:0.00%
controls:0.80%
—
—
—
—
—
0
5
108
1033
0
8
104
995
Limited function/disability NOS
A28 [2002000162]
-1.0e+50
—
-1.0e+50
—
—
-1.0e+50
—
cases:0.00%
controls:1.07%
—
—
cases:0.00%
controls:0.46%
—
—
—
—
cases:0.00%
controls:0.87%
—
—
0
11
105
1017
—
0
5
111
1075
—
—
0
9
108
1029
—
Erythrocytes [Presence] in Urine
33051-4 [3045424]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 [2002330110]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.56%
cases:0.00%
controls:1.02%
—
—
—
—
—
—
—
—
—
—
0
16
105
1012
0
11
111
1069
—
—
—
—
—
Ambulatory ECG
XF404 [2001303370]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Psychiatry
26 [38004469]
5.2e-01
—
-1.0e+50
—
-1.0e+50
—
1.0e+00
cases:6.67%
controls:4.09%
—
—
cases:0.00%
controls:0.83%
—
—
cases:0.00%
controls:1.12%
—
—
cases:12.50%
controls:4.99%
7
42
98
986
—
0
9
111
1071
—
0
12
111
1062
—
13
50
91
953
atorvastatin; oral
C10AA05 [21601860]
—
—
-1.0e+50
—
—
—
-7.3e-02
—
—
—
—
cases:0.00%
controls:1.02%
—
—
—
—
—
—
cases:5.77%
controls:6.18%
—
—
0
11
111
1069
—
—
—
6
62
98
941
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
—
—
-1.0e+50
—
-1.0e+50
1.2e-01
7.3e-02
—
—
—
—
cases:0.00%
controls:1.02%
—
—
cases:0.00%
controls:1.02%
cases:4.63%
controls:4.14%
cases:15.38%
controls:14.46%
—
—
0
11
111
1069
—
0
11
111
1063
5
43
103
995
16
145
88
858
Antenatal screening for malformation
717800004 [36713462]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
cases:0.00%
controls:0.96%
—
—
—
0
5
111
1075
—
—
—
0
10
108
1028
—
Asthma
J45 [45596282]
1.3e+00
—
—
—
—
—
8.6e-01
cases:6.67%
controls:1.85%
—
—
—
—
—
—
—
—
—
—
cases:4.81%
controls:2.09%
7
19
98
1009
—
—
—
—
—
5
21
99
982
Assessment of need for oral health care, standard
SAD01 [2001310287]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.87%
—
—
—
—
—
—
—
0
9
108
1029
—
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
—
—
-1.0e+50
—
—
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
0
5
111
1075
—
—
0
6
108
1032
—
Surveillance of (intrauterine) contraceptive device
Z30.5 [45547300]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Basic examination of mouth
SAA02 [2001310275]
-1.0e-01
—
—
—
—
2.7e-01
-6.5e-02
cases:10.48%
controls:11.48%
—
—
—
—
—
—
—
—
cases:4.63%
controls:3.56%
cases:16.35%
controls:17.25%
11
118
94
910
—
—
—
—
5
37
103
1001
17
173
87
830
tizanidine; oral
M03BX02 [21604116]
3.7e-01
3.7e-01
—
—
—
8.5e-01
3.7e-01
cases:13.33%
controls:9.63%
cases:4.50%
controls:3.15%
—
—
—
—
—
—
cases:4.63%
controls:2.02%
cases:11.54%
controls:8.28%
14
99
91
929
5
34
106
1046
—
—
—
5
21
103
1017
12
83
92
920
Other hammer toe(s) (acquired)
M20.4 [45562664]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Other specified intervertebral disc degeneration
M51.3 [45591865]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
105
1019
—
—
—
—
—
—
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
2.3e-01
1.7e-03
—
—
-1.0e+50
3.1e-01
1.3e-01
cases:5.71%
controls:4.57%
cases:6.31%
controls:6.30%
—
—
—
—
cases:0.00%
controls:1.12%
cases:5.56%
controls:4.14%
cases:10.58%
controls:9.37%
6
47
99
981
7
68
104
1012
—
—
0
12
111
1062
6
43
102
995
11
94
93
909
pH of Venous blood
2746-6 [3012544]
—
—
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
cases:0.00%
controls:1.93%
cases:0.00%
controls:3.39%
—
—
—
—
0
6
111
1068
0
20
108
1018
0
34
104
969
Other medical or dental certificate
WZA90 [2001310883]
—
—
—
—
—
—
7.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.77%
controls:2.79%
—
—
—
—
—
—
6
28
98
975
cromoglicic acid; nasal
R01AC01 [21605033]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
—
—
-1.0e+50
—
—
—
-3.3e-01
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
cases:4.81%
controls:6.58%
—
—
0
6
111
1074
—
—
—
5
66
99
937
Tear of meniscus, current
S83.2 [45555441]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
metformin and sitagliptin
A10BD07 [21600772]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.50%
—
—
—
—
—
0
6
108
1032
0
5
104
998
esomeprazole; oral, parenteral
A02BC05 [21600100]
6.1e-01
—
-1.0e+50
—
-1.0e+50
—
1.6e-01
cases:7.62%
controls:4.28%
—
—
cases:0.00%
controls:0.65%
—
—
cases:0.00%
controls:0.47%
—
—
cases:6.73%
controls:5.78%
8
44
97
984
—
0
7
111
1073
—
0
5
111
1069
—
7
58
97
945
dexamethasone and antiinfectives
S01CA01 [21603652]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.40%
—
—
—
—
—
—
0
14
104
989
furosemide; oral, parenteral
C03CA01 [21601518]
1.0e+00
—
—
—
—
7.2e-01
5.0e-01
cases:7.62%
controls:2.82%
—
—
—
—
—
—
—
—
cases:4.63%
controls:2.31%
cases:5.77%
controls:3.59%
8
29
97
999
—
—
—
—
5
24
103
1014
6
36
98
967
Orthodontic band in one tooth
SJC10 [2001310432]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
pH of Capillary blood
2745-8 [3009343]
—
—
—
—
-1.0e+50
—
7.2e-01
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.65%
—
—
cases:4.81%
controls:2.39%
—
—
—
—
0
7
111
1067
—
5
24
99
979
Open bite
K07.24 [2000502770]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Bacteria identified in Cerebral spinal fluid by Culture
606-4 [3016914]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1075
—
—
—
—
—
poliomyelitis, trivalent, inactivated, whole virus
J07BF03 [21601352]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1075
—
—
—
—
—
Peak expiratory flow measurement
SPAT1057 [2001700158]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Extensive health check-up at 18 months of age
SPAT1382 [2001700482]
-1.0e+50
—
-1.0e+50
—
—
—
—
cases:0.00%
controls:0.78%
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
0
8
105
1020
—
0
5
111
1075
—
—
—
—
Personal history of leukaemia
Z85.6 [45609980]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
ranitidine bismuth citrate; oral
A02BA07 [21600088]
1.4e+00
—
—
—
—
—
—
cases:5.71%
controls:1.46%
—
—
—
—
—
—
—
—
—
—
—
—
6
15
99
1013
—
—
—
—
—
—
Fracture of upper end of humerus
S42.2 [45544677]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Gonarthrosis, unspecified
M17.9 [45606128]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
8
104
995
plastic IUD with progestogen; implant
G02BA03 [21602449]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.79%
—
0
5
111
1075
—
—
—
—
0
18
104
985
Acute sinusitis, unspecified
J01.9 [45543252]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
—
—
—
—
—
-1.0e+50
7.2e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.87%
cases:5.77%
controls:2.89%
—
—
—
—
—
0
9
108
1029
6
29
98
974
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Ear pain/earache
H01 [2002000475]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
0
6
108
1032
—
Dietary counselling and surveillance
Z71.3 [45552101]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.78%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
0
8
105
1020
—
—
—
—
—
0
7
104
996
insulins and analogues for injection, intermediate-acting - combinations; parenteral
A10AC30 [21600727]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.25%
—
—
—
—
—
—
—
0
13
108
1025
—
Extensive MRI examination of brain with high intensity magnet
AA1CG [2001300116]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:1.26%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
0
13
105
1015
—
—
—
—
—
0
5
104
998
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
2.1e-01
—
—
—
—
—
2.0e-01
cases:4.76%
controls:3.89%
—
—
—
—
—
—
—
—
—
—
cases:4.81%
controls:3.99%
5
40
100
988
—
—
—
—
—
5
40
99
963
orphenadrine, combinations
M03BC51 [21604113]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.67%
—
—
—
—
—
—
—
0
7
108
1031
—
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
0
9
104
994
Orthodontic treatment/control appointment
SJX20 [2001310454]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
0
9
104
994
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
—
—
—
—
—
—
3.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.73%
controls:4.99%
—
—
—
—
—
—
7
50
97
953
Amino acids [Identifier] in Serum or Plasma
12468-5 [3013336]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1075
—
—
—
—
—
Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5253-0 [3027545]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1075
—
—
—
—
—
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
0
5
105
1023
—
—
—
—
—
0
5
104
998
Skin colour change
S08 [2002000973]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
-1.2e-01
-1.1e-01
—
-1.0e+50
—
-7.6e-01
1.8e-01
cases:13.33%
controls:14.79%
cases:12.61%
controls:13.89%
—
—
cases:0.00%
controls:0.65%
—
—
cases:5.56%
controls:11.18%
cases:27.88%
controls:24.33%
14
152
91
876
14
150
97
930
—
0
7
111
1073
—
6
116
102
922
29
244
75
759
metronidazole; oral, rectal
P01AB01 [21604857]
—
—
—
—
—
—
4.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.65%
controls:5.78%
—
—
—
—
—
—
9
58
95
945
Immunohistochemistry procedure
117617002 [4035726]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.68%
cases:0.00%
controls:0.74%
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
0
8
111
1072
—
—
—
—
—
Protein [Mass/volume] in Urine
2888-6 [3037121]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.68%
cases:0.00%
controls:0.65%
—
—
—
—
—
—
cases:0.00%
controls:0.87%
—
—
0
7
105
1021
0
7
111
1073
—
—
—
0
9
108
1029
—
Treatment plan or consultation
WZC00 [2001310885]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.76%
—
—
—
—
—
—
—
—
—
—
—
0
19
111
1061
—
—
—
—
—
Acute tonsillitis, unspecified
J03.9 [45576942]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Thoracal epidural anesthesia
WX302 [2001310795]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
acetylsalicylic acid; oral
B01AC06 [21600991]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
—
—
—
cases:0.00%
controls:0.83%
—
—
—
—
cases:0.00%
controls:0.56%
cases:0.00%
controls:0.96%
—
—
—
0
9
111
1071
—
—
0
6
111
1068
0
10
108
1028
—
desloratadine; oral
R06AX27 [21603526]
—
1.1e+00
—
—
—
—
—
—
—
cases:5.41%
controls:1.94%
—
—
—
—
—
—
—
—
—
—
—
6
21
105
1059
—
—
—
—
—
Acute apical periodontitis of pulpal origin
K04.4 [45567286]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
0
9
104
994
carbamide
D02AE01 [21601975]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
0
7
105
1021
—
—
—
—
—
0
5
104
998
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
—
—
—
—
—
—
5.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.81%
controls:2.79%
—
—
—
—
—
—
5
28
99
975
timolol, combinations
S01ED51 [21603705]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.77%
controls:1.20%
—
—
—
—
—
—
6
12
98
991
Delayed milestone
R62.0 [45597195]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:1.07%
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
0
11
105
1017
0
5
111
1075
—
—
—
—
—
hepatitis B, purified antigen
J07BC01 [21601338]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
—
-1.0e+50
—
—
—
—
1.1e+00
—
—
cases:0.00%
controls:1.30%
—
—
—
—
—
—
—
—
cases:6.73%
controls:2.39%
—
0
14
111
1066
—
—
—
—
7
24
97
979
Orthodontics
143 [44777673]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
8
104
995
Emergency use of U07.1 | COVID-19, virus identified
U07.1 [45756093]
—
—
—
—
—
—
6.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.81%
controls:2.59%
—
—
—
—
—
—
5
26
99
977
Knee symptom/complaint
L15 [2002000639]
1.6e+00
—
—
—
—
-1.0e+50
7.2e-01
cases:5.71%
controls:1.26%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
cases:5.77%
controls:2.89%
6
13
99
1015
—
—
—
—
0
5
108
1033
6
29
98
974
naproxen; oral, rectal
M01AE02 [21603968]
6.4e-01
4.6e-01
—
—
-1.0e+50
9.9e-01
4.6e-01
cases:19.05%
controls:10.99%
cases:6.31%
controls:4.07%
—
—
—
—
cases:0.00%
controls:0.47%
cases:7.41%
controls:2.89%
cases:13.46%
controls:8.97%
20
113
85
915
7
44
104
1036
—
—
0
5
111
1069
8
30
100
1008
14
90
90
913
Blepharochalasis
H02.3 [45586340]
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:0.00%
—
—
—
—
—
—
—
6
0
102
1038
—
Pregnancy confirmed
Z32.1 [45566418]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 [3020044]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.65%
—
—
—
—
—
—
—
—
—
—
—
0
7
111
1073
—
—
—
—
—
Acute vaginitis
N76.0 [45543891]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Constipation, unspecified
K59.09 [2000502926]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Other angina pectoris stenosed coronary artery
I20.81 [2000502397]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
Lymphoid leukaemia
C91 [45586062]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
scopolamine; oral, parenteral
N05CM05 [21604666]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Spontaneous vertex delivery
O80.0 [45577661]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.65%
—
—
—
—
—
—
cases:0.00%
controls:0.87%
—
—
—
0
7
111
1073
—
—
—
0
9
108
1029
—
fusidic acid
S01AA13 [21603564]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
0
5
111
1075
—
—
—
0
6
108
1032
—
pravastatin; oral
C10AA03 [21601858]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.10%
—
—
—
—
—
—
0
11
104
992
hydrocortisone and antiinfectives
S03CA04 [21605208]
1.1e+00
—
—
—
—
-1.0e+50
—
cases:5.71%
controls:2.04%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.67%
—
—
6
21
99
1007
—
—
—
—
0
7
108
1031
—
Physiotherapy
R4110 [2001310233]
—
—
-1.0e+50
—
—
—
5.6e-01
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
cases:5.77%
controls:3.39%
—
—
0
5
111
1075
—
—
—
6
34
98
969
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
0
6
108
1032
—
Hypothyroidism, unspecified
E03.9 [45537945]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.78%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.10%
0
8
105
1020
—
—
—
—
—
0
11
104
992
Physical Medicine And Rehabilitation
25 [38004468]
—
—
—
—
—
—
1.8e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.69%
controls:6.48%
—
—
—
—
—
—
8
65
96
938
Urinary frequency/urgency
U02 [2002001138]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
105
1019
—
—
—
—
—
—
candesartan; oral
C09CA06 [21601829]
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:2.22%
cases:0.00%
controls:0.65%
—
—
—
—
—
—
—
—
—
0
24
111
1056
0
7
111
1073
—
—
—
—
hydroxychloroquine; oral
P01BA02 [21604889]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.68%
cases:0.00%
controls:0.74%
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
0
7
105
1021
0
8
111
1072
—
—
—
0
5
108
1033
—
Menopausal and female climacteric states
N95.1 [45548683]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
105
1019
—
—
—
—
—
—
glycerol
A06AX01 [21600597]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Acute upper respiratory infections of multiple and unspecified sites
J06 [45601116]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Orthostatic test
SPAT1101 [2001700202]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Ventricular tachycardia
I47.2 [45586586]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Other specified urinary incontinence
N39.4 [45577525]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Recording of ECG
SPAT1097 [2001700198]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.00%
—
0
6
111
1074
—
—
—
—
0
10
104
993
Cervicobrachial syndrome
M53.1 [45567577]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
105
1019
—
—
—
—
—
—
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
—
—
—
—
—
-1.0e+50
3.9e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.25%
cases:4.81%
controls:3.29%
—
—
—
—
—
0
13
108
1025
5
33
99
970
triamcinolone and antiseptics
D07BB03 [21602150]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.67%
—
—
—
—
—
—
—
0
7
108
1031
—
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
—
—
—
—
—
0
5
108
1033
—
Adenocarcinoma, NOS, of prostate gland
8140/3-C61.9 [44499685]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Oxygen saturation in Arterial blood
2708-6 [3016502]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
0
5
111
1075
—
—
—
0
6
108
1032
—
Diabetes mellitus arising in pregnancy
O24.4 [45543922]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
Assessment of need for oral health care, extensive
SAD02 [2001310288]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
8
104
995
Type 1 diabetes mellitus, With ophthalmic complications
E10.3 [45552380]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
0
5
111
1075
—
—
—
—
—
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
3.8e-01
8.7e-01
-1.0e+50
—
—
—
4.0e-01
cases:8.57%
controls:6.03%
cases:4.50%
controls:1.94%
cases:0.00%
controls:0.46%
—
—
—
—
—
—
cases:8.65%
controls:5.98%
9
62
96
966
5
21
106
1059
0
5
111
1075
—
—
—
9
60
95
943
betamethasone
S02BA07 [21605169]
—
—
—
—
—
-1.0e+50
8.2e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.73%
cases:8.65%
controls:3.99%
—
—
—
—
—
0
18
108
1020
9
40
95
963
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
-1.7e-01
—
—
—
-1.0e+50
-4.0e-01
1.3e-01
cases:9.52%
controls:11.09%
—
—
—
—
—
—
cases:0.00%
controls:1.30%
cases:5.56%
controls:8.09%
cases:20.19%
controls:18.15%
10
114
95
914
—
—
—
0
14
111
1060
6
84
102
954
21
182
83
821
Seborrhoeic keratosis
L82 [45548208]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.78%
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
0
8
105
1020
0
6
111
1074
—
—
—
—
—
Cathetrisation of artery
TPH07 [2001309747]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
—
—
—
—
—
—
—
—
—
—
—
0
13
111
1067
—
—
—
—
—
Acute pharyngitis, unspecified
J02.9 [45538472]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
0
7
105
1021
—
—
—
—
—
0
8
104
995
Flexible laryngoscopy
UDQ12 [2001301827]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Atrioventricular block, complete
I44.2 [45576872]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
codeine and ibuprofen
N02AJ08 [1123631]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Obesity
T82 [2002001125]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Atrial fibrillation/flutter
K78 [2002000605]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Other function in accordance with physical therapy nomenclature
SPAT1295 [2001700396]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Insertion of intrauterine device
TLC00 [2001306647]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Polyp of corpus uteri
N84.0 [45596887]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
Abdominal pain epigastric
D02 [2002000301]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
0
5
105
1023
—
—
—
—
—
0
7
104
996
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-5.3e-02
-4.6e-01
—
—
-1.0e+50
—
1.7e-01
cases:6.67%
controls:7.00%
cases:4.50%
controls:6.94%
—
—
—
—
cases:0.00%
controls:1.40%
—
—
cases:14.42%
controls:12.46%
7
72
98
956
5
75
106
1005
—
—
0
15
111
1059
—
15
125
89
878
salbutamol; oral, parenteral
R03CC02 [21603312]
4.2e-01
—
—
—
—
—
1.2e+00
cases:7.62%
controls:5.16%
—
—
—
—
—
—
—
—
—
—
cases:5.77%
controls:1.79%
8
53
97
975
—
—
—
—
—
6
18
98
985
Combined first trimester screening
MA3AE [2001306839]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Major dressing of wound of skin of trunk
QBB10 [2001309842]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
codeine and paracetamol
N02AJ06 [1123647]
3.0e-01
—
—
—
-1.0e+50
8.4e-01
1.2e-01
cases:10.48%
controls:7.98%
—
—
—
—
—
—
cases:0.00%
controls:0.74%
cases:6.48%
controls:2.89%
cases:10.58%
controls:9.47%
11
82
94
946
—
—
—
0
8
111
1066
7
30
101
1008
11
95
93
908
enalapril; oral, parenteral
C09AA02 [21601786]
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
—
—
—
—
—
—
0
9
111
1065
—
—
Depressive disorder
P76 [2002000870]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
0
6
108
1032
—
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
—
—
—
—
—
—
1.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:7.69%
controls:6.58%
—
—
—
—
—
—
8
66
96
937
Memory disturbance
P20 [2002000816]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.83%
—
—
—
—
—
—
—
—
—
—
—
0
9
111
1071
—
—
—
—
—
Speech disorder
N19 [2002000730]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Extensive health check-up on first grade
SPAT1384 [2001700484]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
—
—
—
—
—
0
5
108
1033
—
Pregnancy
W78 [2002001269]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
—
—
—
cases:0.00%
controls:0.83%
—
—
—
—
cases:0.00%
controls:0.56%
cases:0.00%
controls:0.67%
—
—
—
0
9
111
1071
—
—
0
6
111
1068
0
7
108
1031
—
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:2.13%
—
—
—
—
cases:0.00%
controls:0.74%
cases:0.00%
controls:1.35%
cases:0.00%
controls:3.09%
—
0
23
111
1057
—
—
0
8
111
1066
0
14
108
1024
0
31
104
972
Hypothyroidism caused by autoimmune thyroiditis
E03.80 [2000501406]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
Shoulder X-ray examination without contrast
NB1AA [2001307225]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Eosinophils [#/volume] in Blood
26449-9 [3013115]
8.4e-03
-3.7e-01
—
—
-1.0e+50
—
1.5e-01
cases:6.67%
controls:6.61%
cases:4.50%
controls:6.39%
—
—
—
—
cases:0.00%
controls:1.30%
—
—
cases:13.46%
controls:11.76%
7
68
98
960
5
69
106
1011
—
—
0
14
111
1060
—
14
118
90
885
Back symptom/complaint
L02 [2002000627]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.65%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
0
7
111
1073
—
—
—
—
0
9
104
994
Dental caries
K02 [45552906]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
—
-1.0e+50
-1.0e+50
—
-1.0e+50
—
—
—
—
cases:0.00%
controls:2.04%
cases:0.00%
controls:0.65%
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
0
22
111
1058
0
7
111
1073
—
0
5
111
1069
—
—
Deposits [accretions] on teeth betel
K03.65 [2000502690]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.73%
controls:1.40%
—
—
—
—
—
—
7
14
97
989
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 [2001700321]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.17%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
0
12
105
1016
—
—
—
—
0
5
108
1033
—
roxithromycin; oral
J01FA06 [21602974]
4.5e-01
1.0e+00
—
—
—
—
—
cases:8.57%
controls:5.64%
cases:4.50%
controls:1.67%
—
—
—
—
—
—
—
—
—
—
9
58
96
970
5
18
106
1062
—
—
—
—
—
Teeth/gum disease
D82 [2002000380]
7.6e-01
—
—
—
—
—
-2.1e-01
cases:7.62%
controls:3.70%
—
—
—
—
—
—
—
—
—
—
cases:4.81%
controls:5.88%
8
38
97
990
—
—
—
—
—
5
59
99
944
Cephalometry with X-ray
EB1MA [2001301916]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.00%
—
—
—
—
—
—
0
10
104
993
Counselling related to known health issue
SPAT1310 [2001700411]
6.8e-01
—
—
—
—
9.6e-01
5.3e-01
cases:6.67%
controls:3.50%
—
—
—
—
—
—
—
—
cases:4.63%
controls:1.83%
cases:5.77%
controls:3.49%
7
36
98
992
—
—
—
—
5
19
103
1019
6
35
98
968
Other spondylosis with radiculopathy
M47.2 [45591850]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
0
6
105
1022
—
—
—
—
—
0
5
104
998
Hysteroscopic excision of lesion
LCB25 [2001306568]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.80%
—
—
—
—
—
—
0
8
104
995
Periodic health check-up of children and adolescents
SPAT1315 [2001700416]
—
—
—
—
—
—
6.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.65%
controls:4.89%
—
—
—
—
—
—
9
49
95
954
Retinol [Moles/volume] in Serum or Plasma
14905-4 [3013005]
—
—
-1.0e+50
—
—
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
0
6
111
1074
—
—
0
8
108
1030
—
Cardiac arrhythmia NOS
K80 [2002000607]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
0
7
104
996
s-atenolol; oral
C07AB11 [21601693]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
Assessment of need for medical rehabilitation
SPAT1215 [2001700316]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Gas panel - Arterial blood
24336-0 [3019060]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
C reactive protein [Mass/volume] in Capillary blood
48421-2 [3051387]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.10%
—
—
—
—
—
—
0
11
104
992
Base excess in Arterial blood by calculation
1925-7 [3003396]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.65%
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
0
7
111
1073
—
—
—
0
6
108
1032
—
General anaesthesia
WX402 [2001310806]
-1.0e+50
—
—
—
—
—
1.1e+00
cases:0.00%
controls:0.88%
—
—
—
—
—
—
—
—
—
—
cases:7.69%
controls:2.69%
0
9
105
1019
—
—
—
—
—
8
27
96
976
Thrombin time
3243-3 [3036489]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
0
6
108
1032
—
midazolam; nasal, oral, parenteral, sublingual
N05CD08 [21604643]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
0
9
104
994
azithromycin; oral, parenteral
J01FA10 [21602978]
1.3e-01
1.7e-01
—
—
-1.0e+50
6.0e-01
-5.2e-01
cases:17.14%
controls:15.37%
cases:6.31%
controls:5.37%
—
—
—
—
cases:0.00%
controls:0.47%
cases:6.48%
controls:3.66%
cases:6.73%
controls:10.87%
18
158
87
870
7
58
104
1022
—
—
0
5
111
1069
7
38
101
1000
7
109
97
894
Treatment-related counselling outside office
SPAT1249 [2001700350]
—
-1.0e+50
—
—
—
-1.0e+50
-7.8e-03
—
—
cases:0.00%
controls:1.67%
—
—
—
—
—
—
cases:0.00%
controls:1.54%
cases:6.73%
controls:6.78%
—
0
18
111
1062
—
—
—
0
16
108
1022
7
68
97
935
Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5257-1 [3010521]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.65%
—
—
—
—
—
—
—
—
—
—
—
0
7
111
1073
—
—
—
—
—
Contusion of other and unspecified parts of foot
S90.3 [45584475]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
cases:0.00%
controls:0.80%
—
—
—
—
—
0
5
108
1033
0
8
104
995
chloramphenicol
S02AA01 [21605147]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.78%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.20%
0
8
105
1020
—
—
—
—
—
0
12
104
991
Child behaviour symptom/complaint
P22 [2002000817]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
105
1023
—
—
—
—
—
—
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: current
SMOKING-1-1-1 [2002330115]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.65%
—
—
—
—
—
—
—
—
—
—
—
—
0
17
105
1011
—
—
—
—
—
—
Melaena
K92.1 [45533624]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
fluticasone, combinations
R01AD58 [43534837]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.06%
—
—
—
—
—
—
—
0
11
108
1027
—
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:1.48%
—
—
—
—
—
—
—
—
—
—
—
0
16
111
1064
—
—
—
—
—
Migraine, unspecified
G43.9 [45595943]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
-1.3e-01
-8.3e-01
—
—
—
-3.6e-01
1.6e-01
cases:11.43%
controls:12.84%
cases:4.50%
controls:9.72%
—
—
—
—
—
—
cases:6.48%
controls:9.06%
cases:25.00%
controls:22.13%
12
132
93
896
5
105
106
975
—
—
—
7
94
101
944
26
222
78
781
calcipotriol; ointment
D05AX02 [21602039]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
—
—
—
—
—
—
0
5
104
998
frovatriptan; oral
N02CC07 [21604382]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.90%
—
—
—
—
—
—
0
9
104
994
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
cases:0.00%
controls:1.00%
—
—
—
—
—
0
5
108
1033
0
10
104
993
Unspecified fall
W19 [45756257]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
—
0
6
111
1074
—
—
—
—
—
Laparoscopic cholecystectomy
JKA21 [2001305294]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Spirometry
127783003 [4133840]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
105
1022
—
—
—
—
—
—
dexamethasone; oral, parenteral
H02AB02 [21602730]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.46%
—
—
—
—
—
—
—
—
—
—
—
—
0
15
105
1013
—
—
—
—
—
—
Ankle symptom/complaint
L16 [2002000640]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.88%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
0
9
105
1019
—
—
—
—
0
5
108
1033
—
Acute bronchitis, unspecified
J20.9 [45562445]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1075
—
—
—
—
—
Personal history of diseases of the digestive system
Z87.1 [45542474]
4.4e-01
—
—
—
—
—
2.2e-01
cases:6.67%
controls:4.38%
—
—
—
—
—
—
—
—
—
—
cases:6.73%
controls:5.48%
7
45
98
983
—
—
—
—
—
7
55
97
948
Functional dyspepsia
K30 [45591584]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
cases:0.00%
controls:1.30%
—
—
—
—
—
0
5
108
1033
0
13
104
990
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-5.2e-02
-7.6e-02
—
-1.0e+50
3.6e-01
2.5e-01
1.6e-01
cases:18.10%
controls:18.87%
cases:18.02%
controls:19.17%
—
—
cases:0.00%
controls:0.74%
cases:5.41%
controls:3.82%
cases:21.30%
controls:17.44%
cases:35.58%
controls:32.00%
19
194
86
834
20
207
91
873
—
0
8
111
1072
6
41
105
1033
23
181
85
857
37
321
67
682
Orthodontic treatment/control appointment, short
SJX10 [2001310452]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.00%
—
—
—
—
—
—
0
10
104
993
alprazolam; oral
N05BA12 [21604577]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1075
—
—
—
—
—
Chronic hypertension
205 [2001600203]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.78%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
0
8
105
1020
—
—
—
—
—
0
5
104
998
phenoxymethylpenicillin; oral
J01CE02 [21602842]
6.4e-01
8.7e-01
—
—
—
—
-4.3e-01
cases:22.86%
controls:13.52%
cases:7.21%
controls:3.15%
—
—
—
—
—
—
—
—
cases:8.65%
controls:12.76%
24
139
81
889
8
34
103
1046
—
—
—
—
9
128
95
875
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
-4.3e-02
-3.4e-01
—
—
—
-5.6e-02
2.0e-01
cases:11.43%
controls:11.87%
cases:6.31%
controls:8.61%
—
—
—
—
—
—
cases:7.41%
controls:7.80%
cases:23.08%
controls:19.64%
12
122
93
906
7
93
104
987
—
—
—
8
81
100
957
24
197
80
806
Obstetrics / Gynecology
16 [38004461]
2.1e-01
—
—
—
-1.0e+50
—
1.4e-01
cases:13.33%
controls:11.09%
—
—
—
—
—
—
cases:0.00%
controls:0.84%
—
—
cases:11.54%
controls:10.17%
14
114
91
914
—
—
—
0
9
111
1065
—
12
102
92
901
Chronic maxillary sinusitis
J32.0 [45586667]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
0
7
105
1021
—
—
—
—
—
0
7
104
996
Restoration involving the entire crown of the tooth
SFA40 [2001310361]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.67%
—
—
—
—
—
—
—
0
7
108
1031
—
combinations of penicillins
J01CR50 [21602867]
5.4e-01
—
—
—
—
-1.0e+50
—
cases:4.76%
controls:2.82%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.35%
—
—
5
29
100
999
—
—
—
—
0
14
108
1024
—
Excessive ear wax
H81 [2002000536]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.87%
—
—
—
—
—
—
—
0
9
108
1029
—
Postmenopausal atrophic vaginitis
N95.2 [45582430]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
105
1021
—
—
—
—
—
—
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
0
5
111
1075
—
—
—
—
—
Student oral health check consistent with decree to assess need for oral health guidance and services
WYA50 [2001310877]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.50%
0
7
105
1021
—
—
—
—
—
0
5
104
998
fusidic acid
D09AA02 [21602265]
2.4e-01
—
—
—
—
—
—
cases:4.76%
controls:3.79%
—
—
—
—
—
—
—
—
—
—
—
—
5
39
100
989
—
—
—
—
—
—
Contusion of hip
S70.0 [45574306]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
—
—
—
0
6
104
997

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
116
2.55
3.97
1.3
1.7
901.71
1267.02
nmol/l
1.33
20
90
6
12
5.18
2.43
1.5
3.9
1.68
1.58
umol/l
—
6
12
6
16
3.88
1.96
1.3
3.1
9.50
8.25
%
—
6
16
6
16
3.88
1.96
1.3
3.2
71.50
64.75
%
—
6
16
6
16
3.88
1.96
1.3
2.6
13.67
19.13
%
—
6
16
6
16
3.88
1.96
1.3
2.6
23.00
22.69
%
—
6
16
25
146
1.88
1.96
2.5
2.4
20.07
24.44
%
1.01
25
140
5
12
4.29
1.84
3.6
4.0
3.70
3.44
ug/l
—
5
12
7
23
3.16
1.82
8.0
5.5
—
—
—
0
0
122
1126
2.54
1.82
15.5
11.5
—
—
—
0
0
100
860
1.72
1.80
4.1
3.9
14.91
14.68
pmol/l
0.39
91
793
51
373
1.61
1.80
2.3
1.8
100.88
95.89
pmol/l
0.26
29
196
23
136
1.84
1.73
1.7
1.6
—
—
—
0
0
42
298
1.61
1.66
2.5
2.4
2.37
2.56
mg/l
0.33
37
268
6
20
3.09
1.60
4.8
3.0
10.33
12.06
mu/l
—
6
20
27
172
1.72
1.60
2.4
2.4
13.00
14.02
umol/l
0.30
27
163
118
1087
2.00
1.40
15.6
14.0
26.20
23.00
mg/l
0.40
91
868
47
356
1.50
1.36
6.7
6.7
—
—
—
0
0
57
452
1.47
1.31
6.5
10.5
1.21
1.22
mmol/l
0.45
51
425
5
18
2.85
1.29
1.2
1.2
—
—
—
0
0
58
465
1.45
1.25
2.6
3.1
—
—
estimate
—
0
0
17
102
1.77
1.23
5.8
9.6
—
—
—
0
0
5
19
2.69
1.22
1.2
2.6
44.02
34.43
%
—
5
19
5
20
2.56
1.16
4.2
5.4
4.82
5.13
pmol/l
—
5
20
45
350
1.44
1.12
1.7
1.9
—
—
—
0
0
5
22
2.32
1.04
1.0
1.0
—
—
—
0
0
98
883
1.46
1.02
3.8
3.6
1.27
1.24
mmol/l
0.15
89
830
97
874
1.44
0.99
5.9
5.1
38.35
37.65
mmol/mol
0.31
90
827
104
950
1.49
0.98
4.9
4.6
2.83
2.67
mmol/l
1.25
95
898
34
257
1.44
0.97
7.4
4.6
—
—
—
0
0
48
387
1.38
0.95
8.5
10.4
1.10
1.18
inr
0.86
43
323
119
1123
1.77
0.93
17.3
15.7
67.18
70.88
umol/l
1.26
119
1110
16
103
1.63
0.93
1.3
1.5
—
—
—
0
0
13
79
1.72
0.92
1.8
1.8
—
—
—
0
0
103
944
1.45
0.91
4.4
4.2
4.61
4.52
mmol/l
0.45
94
894
59
497
1.34
0.88
6.4
10.4
1.21
1.22
mmol/l
0.49
51
440
47
383
1.36
0.86
9.8
8.1
—
—
—
0
0
6
31
1.98
0.85
1.8
3.5
135.83
132.44
g/l
—
6
25
107
992
1.46
0.84
5.4
4.8
1.83
1.86
mu/l
0.11
101
931
35
274
1.38
0.82
3.4
4.0
7.39
7.40
ph
0.36
19
189
39
311
1.36
0.82
2.3
3.6
22.09
24.88
ng/l
0.21
20
193
15
99
1.58
0.80
1.2
1.7
3.47
3.39
mmol/l
—
8
75
9
55
1.68
0.75
3.2
3.4
22.11
21.06
s
—
9
50
16
109
1.53
0.75
1.1
1.2
—
—
—
0
0
5
26
1.96
0.71
8.8
5.2
7.41
7.44
ph
—
5
26
17
119
1.49
0.71
1.8
1.4
—
—
—
0
0
7
42
1.70
0.69
1.0
1.1
1.40
1.45
g/l
—
7
42
7
42
1.70
0.69
1.0
2.0
—
—
—
0
0
32
254
1.35
0.69
1.6
1.6
17.36
22.30
nmol/l
1.40
27
222
7
43
1.66
0.68
1.0
1.2
0.91
0.83
g/l
—
7
43
100
929
1.34
0.66
5.0
4.1
5.83
5.69
mmol/l
0.36
94
864
101
943
1.33
0.62
4.5
4.1
1.36
1.42
mmol/l
0.90
94
888
61
539
1.25
0.58
10.7
7.6
8.90
8.36
%
0.85
61
518
83
761
1.25
0.56
7.8
8.0
80.05
88.07
u/l
0.98
83
727
18
235
0.73
0.56
1.9
1.8
—
—
—
0
0
62
551
1.24
0.55
10.5
7.2
57.24
53.67
%
1.72
62
538
14
100
1.45
0.54
6.6
9.7
23.86
24.20
mmol/l
0.38
14
100
9
62
1.48
0.54
1.2
1.2
—
—
—
0
0
18
136
1.38
0.52
1.2
1.2
—
—
—
0
0
22
172
1.34
0.52
5.0
3.2
34.22
416.49
ng/l
—
9
110
67
603
1.23
0.52
10.5
8.3
0.25
0.20
e9/l
0.80
62
522
60
534
1.23
0.52
10.8
7.6
0.60
0.62
%
0.16
60
511
17
128
1.38
0.51
1.2
1.6
—
—
—
0
0
73
665
1.23
0.50
12.3
11.2
4.22
4.12
e9/l
0.13
67
576
40
342
1.25
0.49
3.2
3.5
8.59
249.79
e6/l
0.69
33
261
17
129
1.37
0.49
7.0
15.0
24.91
25.12
mmol/l
0.11
17
129
60
537
1.22
0.48
10.8
7.5
2.73
2.85
%
0.16
60
514
22
176
1.30
0.45
1.4
1.3
1.12
6.54
u/ml
—
6
66
45
395
1.21
0.43
2.6
2.6
—
—
—
0
0
62
562
1.20
0.43
10.7
7.3
27.67
31.49
%
2.11
62
543
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
171.25
—
0
16
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
5
34
1.49
0.41
1.8
1.2
—
—
—
0
0
8
61
1.33
0.40
11.3
17.0
0.73
0.62
%
—
8
61
38
334
1.20
0.36
2.7
2.8
—
—
—
0
0
66
609
1.17
0.35
10.1
7.8
2.11
2.18
e9/l
0.22
61
537
18
146
1.27
0.34
2.6
1.9
—
—
—
0
0
6
45
1.35
0.34
1.3
1.8
—
—
—
0
0
45
405
1.17
0.32
4.0
4.3
18.76
61.25
e6/l
1.08
36
273
32
282
1.18
0.29
4.0
2.6
—
—
—
0
0
33
292
1.17
0.29
2.9
3.0
—
—
estimate
—
0
0
29
329
0.85
0.29
1.7
1.6
1.96
2.08
g/l
0.16
18
191
8
63
1.29
0.28
11.3
16.6
1.78
1.28
%
—
8
63
5
40
1.26
0.22
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
254.21
—
0
10
33
299
1.14
0.21
3.0
3.1
1.10
0.41
e6/l
0.32
26
219
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
22
194
1.16
0.20
1.5
1.3
13.54
30.16
iu/ml
—
10
52
6
50
1.21
0.20
1.0
1.1
—
—
—
0
0
10
81
1.25
0.19
1.3
2.1
—
0.00
estimate
—
0
23
12
100
1.22
0.19
8.9
12.4
7.39
7.42
ph
—
6
54
39
361
1.12
0.18
1.4
1.6
—
—
—
0
0
8
70
1.15
0.16
1.3
1.6
—
—
—
0
0
15
130
1.17
0.16
9.3
12.5
105.80
104.74
mmol/l
0.55
15
130
12
102
1.19
0.16
9.1
12.1
5.87
5.22
kpa
1.62
12
97
12
102
1.19
0.16
9.1
12.1
13.49
13.40
kpa
0.02
12
97
7
87
0.79
0.15
1.7
1.8
0.85
1.12
g/l
—
7
82
25
273
0.90
0.14
5.0
6.0
—
—
—
0
0
13
113
1.17
0.13
1.2
1.3
—
—
—
0
0
32
298
1.10
0.13
1.5
1.8
—
—
—
0
0
36
381
0.92
0.11
1.8
2.3
—
—
—
0
0
6
56
1.07
0.09
1.3
1.2
—
—
—
0
0
30
317
0.93
0.08
3.3
3.9
0.00
0.00
estimate
—
8
113
31
327
0.93
0.08
3.7
2.9
0.00
0.00
estimate
—
9
95
7
63
1.12
0.08
1.4
1.1
—
—
—
0
0
7
67
1.05
0.08
1.0
1.0
—
—
—
0
0
7
67
1.05
0.08
8.6
13.4
1.11
1.16
mg/l
—
7
61
7
80
0.87
0.07
3.1
3.1
—
—
—
0
0
11
122
0.89
0.07
2.2
1.6
—
—
—
0
0
11
122
0.89
0.07
2.2
1.7
—
—
—
0
0
11
122
0.89
0.07
2.2
1.6
—
—
—
0
0
11
122
0.89
0.07
2.2
1.6
—
—
—
0
0
9
102
0.87
0.06
2.3
8.4
23.31
23.49
mmol/l
—
9
102
43
445
0.95
0.06
3.7
3.3
0.00
0.01
estimate
—
8
101
24
227
1.07
0.06
2.2
2.4
1.45
0.82
mg/l
0.54
15
182
24
233
1.04
0.01
1.5
2.0
—
—
—
0
0
35
357
0.97
0.01
1.5
1.5
0.44
3.02
u/ml
—
7
78
56
553
1.02
0.01
13.0
12.1
0.00
0.00
e9/l
0.41
44
445
22
214
1.03
0.00
1.3
1.6
—
—
—
0
0
58
586
0.98
0.00
3.8
3.6
0.00
0.00
estimate
—
9
116
58
586
0.98
0.00
3.7
3.6
0.00
0.00
estimate
-0.00
11
123
11
114
0.96
0.00
2.2
1.6
—
—
—
0
0
11
109
1.01
0.00
2.1
4.0
0.18
0.22
g/l
0.71
11
103
13
129
1.01
0.00
8.5
11.5
—
—
—
0
0
13
127
1.03
0.00
2.5
2.8
0.73
0.71
ug/l
—
6
76
24
243
0.98
0.00
3.7
3.3
56.25
95.33
mg/l
0.42
15
157
10
98
1.02
0.00
1.6
1.4
—
—
—
0
0
24
245
0.97
0.00
4.5
4.0
11.07
88.20
mg/mmol
0.54
16
154
58
581
1.00
0.00
3.5
3.5
0.00
0.00
estimate
-0.00
11
121
28
276
1.02
0.00
4.5
3.3
1.02
1.02
kg/l
0.40
22
175
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
9
89
1.01
-0.00
3.0
3.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
0.00
—
0
8
0
5
0.00
-0.00
0.0
1.4
—
98.92
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
8.98
—
0
6
0
6
0.00
-0.00
0.0
1.7
—
87.83
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
52
0.96
-0.00
1.6
3.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
100.00
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
48
480
1.00
-0.00
3.2
2.9
6.33
6.18
ph
0.38
24
257
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
25.12
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
162.50
—
0
6
0
6
0.00
-0.00
0.0
2.0
—
5.27
—
0
6
0
5
0.00
-0.00
0.0
8.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.0
—
0.57
—
0
7
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
9
91
0.99
-0.00
2.1
4.0
67.22
67.90
e9/l
—
9
64
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
68.17
—
0
6
8
87
0.91
-0.00
4.0
3.1
3.53
0.19
e6/l
—
8
82
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.9
—
164.86
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: Q17_CONGENITAL_PTOSIS – Congenital ptosis

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).